Collectively, the results from the study by Rothchild et al. establish the kinetics of T cell GM-CSF production during experimental TB, quantify conventional and nonconventional T cells’ contribution to GM-CSF levels at each disease stage, establish the protective nature of GM-CSF-producing T cells, and provide a mechanistic basis for their protective capacity. This evidence concerns the gene CSF2 and tuberculosis.